Scope is a healthcare and pharmaceuticals company supplying ophthalmics and food supplement products, including probiotics and multivitamins, in Ireland, the UK and the USA.
Scope is a healthcare and pharmaceuticals company founded in 2009 by brothers John and Tom Freyne, who built the business on an 80-year family heritage in the sector. The firm supplies healthcare professionals and patients with research-based products across two divisions: ophthalmics and healthcare, spanning pharmaceuticals, nutraceuticals, probiotics, food supplements and multivitamins, with product research and development at the core of its operations.
The ophthalmics division develops eyecare products for Age-Related Macular Degeneration (AMD) and Ocular Surface Diseases, including Dry Eye Disease, Blepharitis and Meibomian Gland Dysfunction (MGD). The healthcare division offers the Bio-Kult probiotics range, the Vivio Junior Multivitamin and Vivimune, an immunity tonic.
Scope operates in three countries - Ireland, the United Kingdom and the United States of America. The company states a commitment to ethical, high-professional standards in all its operations, a focus on premium, research-based products, and strong relationships with healthcare professionals, with a stated aim of exceeding the expectations of healthcare partners, patients and employees.
